NEW YORK (GenomeWeb News) – Beckman Coulter will sell CompuCyte's laser scanning cytometers to cellular-analysis customers worldwide under a distribution agreement announced by the companies today.
Under the five-year agreement, Beckman Coulter will have exclusive distribution rights for CompuCyte's iGeneration technology outside of North America, and will share with CompuCyte the right to sell the instruments to research institutions and pharmaceutical companies in the US, Canada, and Mexico.
In addition, CompuCyte will continue worldwide direct sales of LSC instrumentation for automated tissue analysis applications.
CompuCyte's iGeneration technology encompasses three instrument platforms: the iCyte automated imaging cytometer, which is designed primarily for pharma and biotech companies; the iCys research imaging cytometer for basic research applications; and the iColor fluoro-chromatic imaging cytometer for analyzing fluorescent and chromatically stained specimens.
All of the iGeneration platforms employ laser scanning cytometry technology, which allows flow cytometry-like analysis of solid samples.
"This agreement provides us with a sophisticated imaging platform that nicely complements our growing flow cytometry product portfolio," Brad Calvin, vice president of flow cytometry for Beckman Coulter, said in a statement.
"This will enable us to provide researchers around the world with a broad range of technology for cell-based research from a single service provider, while further demonstrating our commitment to the research market," Calvin added.